Adial Pharmaceuticals's total assets for Q4 2024 were $5.04M, a decrease of -24.86% from the previous quarter. ADIL total liabilities were $975.86K for the fiscal quarter, a 17.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.